NEO Operating Income Growth
Neogenomics Inc · Operating Income Growth
NEO Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported42.49%period ending
NEO TTM Operating Income YoY % (-60.85% → 42.49%)
Year-over-year change
High-resolution chart · PNG
NEO operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 42.489% | |
| -16.4048% | |
| -23.3448% | |
| -30.981% | |
| -20.7542% | |
| 13.4321% | |
| 14.5077% | |
| 20.1359% | |
| 27.1917% | |
| 26.6144% | |
| 31.6496% | |
| 33.1364% | |
| 24.3628% | |
| 9.64% | |
| -32.7307% | |
| -141.1889% | |
| -534.5265% | |
| -553.9318% | |
| -748.7278% | |
| -316.3161% | |
| -49.6487% | |
| -560.91% | |
| -207.5811% | |
| -227.4248% | |
| -232.3455% | |
| -48.7752% | |
| 29.5418% | |
| 15.3767% | |
| 151.131% | |
| 67.994% | |
| 196.8658% | |
| 389.7525% | |
| 1,707.6246% | |
| 1,015.6134% | |
| 31.3398% | |
| -1,474.1497% | |
| 65.4509% | |
| 117.0685% | |
| 145.6965% | |
| -67.3333% | |
| -238.4292% | |
| -349.5645% | |
| -354.0577% | |
| -57.204% | |
| -78.6271% | |
| -61.2933% | |
| -30.1197% | |
| -2.9086% | |
| 936.0248% | |
| 397.4085% | |
| 161.8812% | |
| 20.4002% | |
| -87.2475% | |
| -58.2697% | |
| 233.6553% | |
| 205.2083% | |
| 150.9893% | |
| 100% | |
| 64.4667% | |
| 29.4533% | |
| -24.9955% | |
| -71.5201% | |
| -266.1694% | |
| -543.7159% | |
| -369.3754% | |
| -95.5336% | |
| 40.9022% | |
| 76.0589% | |
| 72.7322% | |
| 15.395% | |
| -60.3487% | |
| -1,161.2409% | |
| -2,410.6217% | |
| -1,014.5883% | |
| -1,951.5208% | |
| 117.5278% | |
| 128.9286% | |
| 91.0765% | |
| 43.2707% | |
| -9.7394% | |
| -37.193% | |
| -37.3345% | |
| -44.2497% | |
| -47.5867% | |
| -151.8628% | |
| -210.9288% | |
| -230.3447% | |
| -696.6887% | |
| 112.552% | |
| 106.1517% | |
| 105.0904% | |
| 99.2039% | |
| -771.9413% | |
| -599.5812% | |
| -598.3634% | |
| -702.6809% | |
| -60.8461% |